ISSN: 2160-763X
Journal Home
Journal Guideline
Clinical Pharmacology in Drug Development Q2 Unclaimed
Clinical Pharmacology in Drug Development is a journal indexed in SJR in Pharmaceutical Science and Pharmacology (medical) with an H index of 30. It has a price of 2500 €. It has an SJR impact factor of 0,637 and it has a best quartile of Q2. It has an SJR impact factor of 0,637.
Type: Journal
Type of Copyright:
Languages:
Open Access Policy:
Type of publications:
Publication frecuency: -
2500 €
Inmediate OANPD
Embargoed OA0 €
Non OAMetrics
0,637
SJR Impact factor30
H Index159
Total Docs (Last Year)358
Total Docs (3 years)3674
Total Refs762
Total Cites (3 years)342
Citable Docs (3 years)2.15
Cites/Doc (2 years)23.11
Ref/DocOther journals with similar parameters
Journal of Pharmaceutical Sciences Q2
Pharmaceutical Research Q2
Journal of Aerosol Medicine and Pulmonary Drug Delivery Q2
Saudi Pharmaceutical Journal Q2
Journal of Pharmaceutical and Biomedical Analysis Q2
Compare this journals
Aims and Scope
Best articles by citations
Aspartame - Is there new information?
View moreA Thorough QT Study to Evaluate the Effects of a Supratherapeutic Dose of Sertraline on Cardiac Repolarization in Healthy Subjects
View moreA thorough QT/QTc study of the effect of fasiglifam, a GPR40 agonist, on cardiac repolarization in healthy adults
View morePharmacokinetics, Safety, and Tolerability Evaluation of Single and Multiple Doses of GSK3342830 in Healthy Volunteers
View morePharmacokinetics, Safety, and Tolerability Following the Administration of a Single Dose of a Combination Tablet Containing Sumatriptan and Naproxen Sodium in Adolescent Patients With Migraine and in Healthy Adult Volunteers
View morePharmacokinetics, Safety, and Tolerability of Once-Daily Intranasal Fluticasone Furoate and Levocabastine Administered Alone or Simultaneously as fluticasone Furoate/Levocabastine Fixed-Dose Combination
View moreBioavailability and Safety of the Factor Xa Inhibitor Edoxaban and the Effects of Quinidine in Healthy Subjects
View morePharmacokinetic Profile of Orally Administered Scyllo-Inositol (Elnd005) in Plasma, Cerebrospinal Fluid and Brain, and Corresponding Effect on Amyloid-Beta in Healthy Subjects
View moreBioavailability of Clindamycin From a New Clindamycin Phosphate 1.2%-Benzoyl Peroxide 3% Combination Gel
View moreA Novel Study Using Accelerated Mass Spectrometry to Evaluate the Pharmacokinetics of Total 14C AL-8309 (Tandospirone) Following Topical Ocular Administration in Healthy Male Subjects
View morePharmacokinetic Studies of Cysteamine Bitartrate Delayed-Release
View moreVolume of distribution - Again
View moreEffects of Trastuzumab Emtansine (T-DM1) on QT Interval and Safety of Pertuzumab Plus T-DM1 in Patients With Previously Treated Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer
View moreRandomized, Double-Blind, Single-Dose, Placebo-Controlled Crossover Study to Evaluate the Effects of Esaxerenone on QTc Interval in Healthy Subjects
View moreEffects of icosapent ethyl (Eicosapentaenoic acid ethyl ester) on pharmacokinetic parameters of rosiglitazone in healthy subjects
View moreAn evaluation of the systemic bioavailability of mometasone furoate (MF) after oral inhalation from a MF/formoterol fumarate metered-dose inhaler versus an MF dry-powder inhaler in healthy subjects
View moreRelative Bioavailability of an Emulsion Formulation for Omega-3-Acid Ethyl Esters Compared to the Commercially Available Formulation: A Randomized, Parallel-Group, Single-Dose Study Followed by Repeat Dosing in Healthy Volunteers
View moreA comparative pharmacokinetic and pharmacodynamic study of FSK0808 versus reference filgrastim after repeated subcutaneous administration in healthy Japanese men
View moreRelative Bioavailability of Liquid and Tablet Formulations of the Antiparasitic Moxidectin
View moreA pharmacokinetic, pharmacodynamic, and safety study of intravenous cyclophosphamide with an oral casopitant antiemetic regimen in cancer patients
View morePharmacokinetics and adhesion of a transdermal patch containing ethinyl estradiol and gestodene under conditions of heat, humidity, and exercise: A single-center, open-label, randomized, crossover study
View moreA Phase 1 Randomized, Placebo-Controlled Trial With a Topical Inhibitor of Stearoyl-Coenzyme A Desaturase 1 Under Occluded and Nonoccluded Conditions
View moreA Phase 1 Study to Evaluate the Bioavailability and Food Effect of 2 Solid-Dispersion Formulations of the TRPV1 Antagonist ABT-102, Relative to the Oral Solution Formulation, in Healthy Human Volunteers
View morePharmacokinetics and Bioequivalence Evaluation of 2 Cefadroxil Suspensions in Healthy Egyptian Male Volunteers
View more
Comments